Zhong Yuan Bio-Technology Holdings Limited
ZHYBF · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.62 | -0.35 | -0.03 | 4.55 |
| FCF Yield | -0.83% | -1.55% | -0.34% | 3.47% |
| EV / EBITDA | 195.34 | -45.96 | -259.11 | 57.26 |
| Quality | ||||
| ROIC | 10.13% | -80.62% | -26.69% | -0.46% |
| Gross Margin | 90.94% | 91.30% | 81.95% | 82.76% |
| Cash Conversion Ratio | -2.74 | 0.59 | 0.35 | -11.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.73% | 0.55% | 24.06% | 10.33% |
| Free Cash Flow Growth | 26.99% | -157.33% | -230.77% | 296.93% |
| Safety | ||||
| Net Debt / EBITDA | 5.20 | -1.19 | -3.45 | 8.41 |
| Interest Coverage | 3.28 | -26.83 | -19.46 | -0.59 |
| Efficiency | ||||
| Inventory Turnover | 6.96 | 1.10 | 7.34 | 0.19 |
| Cash Conversion Cycle | 288.03 | 409.33 | 131.02 | 2,044.25 |